The Disruptors: The Biologic Revolution in Cancer Continues

Grand Ballroom

Tuesday, June 13, 2023

8:30 AM - 9:10 AM

Disruptors

Watch Panel Here

A new generation of oncology drugs is emerging that includes bispecific antibodies, antibody-drug conjugates and other novel feats of protein engineering. Together, these new biologic drugs seek to maximize tumor killing while minimizing immune and healthy tissue toxicities. The panel will discuss this new wave of innovation and what it means for the treatment of solid tumors.

Moderator

Daniel Haber, MD, PhD

Director, Mass General Cancer Center;

Kurt J. Isselbacher Professor of Oncology, HMS

Panelists

Bill Lundberg, MD

CEO, Merus

Thomas Schuetz, MD, PhD

CEO & Co-Founder, Compass Therapeutics

Fred Schwarzer

CEO, IGM Biosciences